Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-16 Sale | 2023-06-20 5:20 pm | uniQure N.V. | QURE | Gut Robert Director | 3,228 | $18.88 | $60,945 | 64,729 (Direct) | View |
| 2023-02-27 Sale | 2023-03-01 4:09 pm | uniQure N.V. | QURE | Gut Robert Director | 1,968 | $20.79 | $40,907 | 42,197 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 4:41 pm | uniQure N.V. | QURE | Gut Robert Director | 1,602 | $16.7 | $26,753 | 35,085 (Direct) | View |
| 2022-01-26 Sale | 2022-01-28 5:08 pm | uniQure N.V. | QURE | Gut Robert Director | 2,348 | $18.12 | $42,546 | 35,153 (Direct) | View |
| 2021-09-21 Sale | 2021-09-22 09:32 am | uniQure N.V. | QURE | Gut Robert Director | 4,500 | $36.61 | $164,745 | 37,501 (Direct) | View |
| 2021-03-02 Sale | 2021-03-04 2:23 pm | uniQure N.V. | QURE | Gut Robert Director | 1,300 | $36.98 | $48,074 | 42,001 (Direct) | View |
| 2021-01-26 Sale | 2021-01-28 10:49 am | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 604 | $39.09 | $23,610 | 40,919 (Direct) | View |
| 2020-09-21 Sale | 2020-09-22 09:48 am | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 4,352 | $39.12 | $170,250 | 41,523 (Direct) | View |
| 2020-06-23 Sale | 2020-06-24 4:21 pm | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 26,875 | $70 | $1,881,250 | 99,000 (Direct) | View |
| 2020-01-27 Sale | 2020-01-29 6:02 pm | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 7,493 | $60.18 | $450,954 | 27,885 (Direct) | View |
| 2019-09-19 Sale | 2019-09-20 2:00 pm | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 4,769 | $47.16 | $224,906 | 35,378 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-13 Option Award | 2023-06-20 5:20 pm | N/A 2033-06-13 | uniQure N.V. | QURE | Gut Robert Director | 25,760 | $0 | 64,729 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:46 pm | N/A 2032-06-15 | uniQure N.V. | QURE | Gut Robert Director | 26,890 | $0 | 61,975 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 5:02 pm | N/A 2032-02-24 | uniQure N.V. | QURE | Gut Robert Director | 4,179 | $0 | 39,332 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 4:36 pm | N/A 2031-02-25 | uniQure N.V. | QURE | Gut Robert Director | 6,489 | $0 | 47,408 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-24 4:21 pm | N/A 2028-06-14 | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 26,875 | $0 | 99,000 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-24 4:21 pm | N/A N/A | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 5,000 | $35.4 | 99,000 (Direct) | View |
| 2020-06-23 Exercise | 2020-06-24 4:21 pm | N/A N/A | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 21,875 | $39.97 | 99,000 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-02 4:05 pm | N/A 2030-02-27 | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 34,099 | $0 | 67,594 (Direct) | View |
| 2020-01-31 Option Award | 2020-01-31 4:17 pm | N/A N/A | uniQure N.V. | QURE | Gut Robert Chief Medical Officer | 5,610 | $0 | 33,495 (Direct) | View |